Beck Mack & Oliver’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $975K | Hold |
1,945
| – | – | 0.02% | 121 |
|
|
2026
Q1 | $956K | Hold |
1,945
| – | – | 0.02% | 114 |
|
|
2025
Q4 | $1.13M | Hold |
1,945
| – | – | 0.02% | 110 |
|
|
2025
Q3 | $943K | Hold |
1,945
| – | – | 0.02% | 114 |
|
|
2025
Q2 | $789K | Hold |
1,945
| – | – | 0.02% | 118 |
|
|
2025
Q1 | $968K | Hold |
1,945
| – | – | 0.02% | 110 |
|
|
2024
Q4 | $1.01M | Buy |
1,945
+604
| +45% | +$332K | 0.02% | 106 |
|
|
2024
Q3 | $830K | Hold |
1,341
| – | – | 0.02% | 114 |
|
|
2024
Q2 | $742K | Hold |
1,341
| – | – | 0.02% | 116 |
|
|
2024
Q1 | $779K | Hold |
1,341
| – | – | 0.02% | 116 |
|
|
2023
Q4 | $712K | Hold |
1,341
| – | – | 0.02% | 119 |
|
|
2023
Q3 | $679K | Hold |
1,341
| – | – | 0.02% | 114 |
|
|
2023
Q2 | $700K | Hold |
1,341
| – | – | 0.02% | 117 |
|
|
2023
Q1 | $773K | Hold |
1,341
| – | – | 0.02% | 116 |
|
|
2022
Q4 | $738K | Hold |
1,341
| – | – | 0.02% | 119 |
|
|
2022
Q3 | $680K | Hold |
1,341
| – | – | 0.02% | 117 |
|
|
2022
Q2 | $729K | Hold |
1,341
| – | – | 0.02% | 118 |
|
|
2022
Q1 | $792K | Hold |
1,341
| – | – | 0.02% | 127 |
|
|
2021
Q4 | $895K | Sell |
1,341
-185
| -12% | -$116K | 0.02% | 123 |
|
|
2021
Q3 | $872K | Buy |
1,526
+85
| +6% | +$46.7K | 0.02% | 121 |
|
|
2021
Q2 | $727K | Hold |
1,441
| – | – | 0.02% | 130 |
|
|
2021
Q1 | $658K | Hold |
1,441
| – | – | 0.02% | 128 |
|
|
2020
Q4 | $671K | Hold |
1,441
| – | – | 0.02% | 130 |
|
|
2020
Q3 | $636K | Hold |
1,441
| – | – | 0.02% | 127 |
|
|
2020
Q2 | $522K | Hold |
1,441
| – | – | 0.02% | 135 |
|
|
2020
Q1 | $409K | Buy |
1,441
+56
| +4% | +$17.7K | 0.02% | 142 |
|
|
2019
Q4 | $450K | Hold |
1,385
| – | – | 0.01% | 152 |
|
|
2019
Q3 | $403K | Hold |
1,385
| – | – | 0.01% | 156 |
|
|
2019
Q2 | $407K | Hold |
1,385
| – | – | 0.01% | 159 |
|
|
2019
Q1 | $379K | Sell |
1,385
-640
| -32% | -$159K | 0.01% | 166 |
|
|
2018
Q4 | $453K | Hold |
2,025
| – | – | 0.02% | 154 |
|
|
2018
Q3 | $494K | Hold |
2,025
| – | – | 0.02% | 158 |
|
|
2018
Q2 | $419K | Hold |
2,025
| – | – | 0.01% | 161 |
|
|
2018
Q1 | $418K | Hold |
2,025
| – | – | 0.01% | 162 |
|
|
2017
Q4 | $385K | Sell |
2,025
-640
| -24% | -$123K | 0.01% | 165 |
|
|
2017
Q3 | $504K | Hold |
2,665
| – | – | 0.02% | 153 |
|
|
2017
Q2 | $465K | Hold |
2,665
| – | – | 0.02% | 162 |
|
|
2017
Q1 | $409K | Hold |
2,665
| – | – | 0.01% | 165 |
|
|
2016
Q4 | $376K | Sell |
2,665
-50
| -2% | -$7.37K | 0.01% | 169 |
|
|
2016
Q3 | $432K | Hold |
2,715
| – | – | 0.02% | 173 |
|
|
2016
Q2 | $401K | Sell |
2,715
-300
| -10% | -$44.3K | 0.01% | 204 |
|
|
2016
Q1 | $427K | Hold |
3,015
| – | – | 0.01% | 197 |
|
|
2015
Q4 | $428K | Sell |
3,015
-82
| -3% | -$10.9K | 0.01% | 203 |
|
|
2015
Q3 | $379K | Hold |
3,097
| – | – | 0.01% | 234 |
|
|
2015
Q2 | $402K | Sell |
3,097
-162
| -5% | -$21.1K | 0.01% | 248 |
|
|
2015
Q1 | $438K | Hold |
3,259
| – | – | 0.01% | 243 |
|
|
2014
Q4 | $408K | Buy |
3,259
+834
| +34% | +$101K | 0.01% | 250 |
|
|
2014
Q3 | $295K | Hold |
2,425
| – | – | 0.01% | 288 |
|
|
2014
Q2 | $286K | Buy |
2,425
+100
| +4% | +$11.8K | 0.01% | 297 |
|
|
2014
Q1 | $280K | Buy |
2,325
+225
| +11% | +$26.8K | 0.01% | 285 |
|
|
2013
Q4 | $234K | Sell |
2,100
-884
| -30% | -$87.9K | 0.01% | 327 |
|
|
2013
Q3 | $275K | Hold |
2,984
| – | – | 0.01% | 288 |
|
|
2013
Q2 | $253K | Buy |
+2,984
| New | +$248K | 0.01% | 295 |
|
Other funds holding TMO
Beck Mack & Oliver's TMO Position: Q2 2026 in Review
Beck Mack & Oliver held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 1,945 shares worth $975K. The position accounts for 0.02% of the portfolio, ranked #121.
Beck Mack & Oliver first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.13M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Beck Mack & Oliver held 1,945 shares of Thermo Fisher Scientific worth $975K as of Q2 2026.
- Beck Mack & Oliver left its Thermo Fisher Scientific share count unchanged in Q2 2026.
- Thermo Fisher Scientific made up 0.02% of Beck Mack & Oliver's portfolio in Q2 2026, its #121 holding.
- Beck Mack & Oliver first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- Beck Mack & Oliver's Thermo Fisher Scientific position peaked at $1.13M in Q4 2025.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Beck Mack & Oliver's 13F filing for Q2 2026, filed 14 Aug 2026.